Abstract
There were an estimated 10 million new cases, 6 million deaths and 22 million persons living with cancer in the year 2000. The most common cancers are, in terms of new cases, lung (1.2 million), breast (1.05 million), colon–rectum (945 000), stomach (876 000) and liver (564 000). The geographic distributions of some 20 types of cancer for which national estimates have been made are summmarized. These patterns are examined with respect to the likely reasons in terms of variation in exposure to carcinogens (in the external environment or through lifestyle choices) or in genetic susceptibility to them. Related data from studies of migrant populations (that allow comparisons of genetically similar populations living in different environments) and from comparisons between different ethnic groups living in the same country are used to help in the interpretation of the geographic patterns. Information on the burden of disease also has a very important role in the planning and monitoring of programmes of cancer control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arbyn M and Geys H . (2002). Int. J. Cancer, 102, 649–654.
Armstrong B and Doll R . (1975). Int. J. Cancer, 15, 617–631.
Bassett MT, Chokunonga E, Mauchaza B, Levy L, Ferlay J and Parkin DM . (1995). Int. J. Cancer, 63, 29–36.
Bergström A, Pisani P, Wolk A and Adami HO . (2001). Int. J. Cancer, 91, 421–430.
Bosch FX, Lorincz A, Munoz N, Meijer CJ and Shah KV . (2002). J. Clin. Pathol., 55, 244–265.
Bouchardy C, Mirra AP, Khlat M, Parkin DM, de Souza JM and Gotlieb SL . (1991). Cancer Epidemiol. Biomarkers Prev., 1, 21–27.
Bouchardy C, Parkin DM, Wanner P and Khlat M . (1996). Int. J. Epidemiol., 25, 5–13.
Bouchardy C, Wanner P and Parkin DM . (1995). Cancer Cause Control, 6, 539–544.
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH and Tulinius H . (1977). Int. J. Cancer, 20, 680–688.
Brinton LA, Benichou J, Gammon MD, Brogan DR, Coates R and Schoenberg JB . (1997). Int. J. Cancer, 73, 349–355.
Coggon D, Osmond C and Barker DJ . (1990). Br. J. Cancer, 61, 573–574.
Correa P, Sasano N, Stemmerman N and Haenszel W . (1973). J. Natl. Cancer Inst., 51, 1449–1459.
Doll R and Peto R . (1981). The Causes of Cancer. Oxford University Press: Oxford.
Donato F, Boffetta P and Puoti M . (1998). Int. J. Cancer, 75, 347–354.
Dorn HF and Cutler SJ . (1959). Morbidity from cancer in the United States: Parts I and II, Public Health Monograph No. 56 US Dept of Health, Education and Welfare: Washington, DC.
Easton DF . (1994). Br. Med. Bull., 50, 527–535.
Editorial committee for the Atlas of Cancer Mortality (1979). Atlas of Cancer Mortality in the People's Republic of China. China Map Press: Beijing.
Ferlay J, Bray F, Pisani P and Parkin DM . (2000). GLOBOCAN 2000: Cancer incidence, mortality and Prevalence Worldwide, IARC Cancer Base No. 5, IARC Press: Lyon.
Fu YS, Berek JS and Hilborne LH . (1987). Appl. Pathol., 5, 47–56.
Geddes M, Parkin DM, Khlat M, Balzi D and Buiatti E (eds) (1993). Cancer in Italian Migrant Populations, IARC Scientific Publication No. 123 IARC: Lyon, France.
Goedde HW, Agarwal DP, Fritze G, Meier TD, Singh S, Beckmann G, Bhatia K, Chen LZ, Fang B, Lisker R, Paik YK, Rothhammer F, Saha N, Segal B, Srivastava LM and Czeizel A . (1992). Hum. Genet., 88, 344–346.
Griffith GW . (1968). Br. J. Cancer, 22, 163–172.
Gustafsson L, Ponten J, Bergström R and Adami HO . (1997). Int. J. Cancer, 71, 159–165.
Hartge P and Devesa SS . (1992). Cancer Res., 52, 5566s–5569s.
Helicobacter and Cancer Collaborative Group (2001). Gut, 49, 347–353.
Hirsch A . (1883). Handbook of Geographical and Historical Pathology. Vols. I–III. The New Sydenham Society: London, Translated from the Second German Edition by Creighton C).
IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 61 (1994). Schistosomes, Liver Flukes and Helicobacter pylori. International Agency for Research on Cancer: Lyon, France.
Ishibe N and Kelsey KT . (1997). Cancer Causes Control, 8, 504–513.
Kolonel LN, Hinds MW and Hankin JH . (1980). Genetic and Environmental factors in Experimental and Human Cancer, Gelboin HV, MacMahon B, Matsushima T, Sugimura T, Takayama S and Takebe H (eds) Japan Scientific Societies Press: Tokyo, Japan, pp. 327–340.
Lauren P . (1965). Acta. Pathol. Microbiol. Scand., 64, 31–49.
Lee HP, Day NE and Shanmugaratnem K . (1988). Trends in Cancer Incidence in Singapore 1868–1882, IARC Scientific Publication No. 91 IARC: Lyon, France.
Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P and Salmasizadeh S . (1973). Br. J. Cancer, 28, 197–214.
McKeown-Eyssen G . (1994). Cancer Epidemiol. Biomarkers Prev., 3, 687–695.
McMichael AJ, McCall MG, Hartshorne JM and Woodings TL . (1980). Int. J. Cancer, 25, 431–437.
McPherson K, Steel CM and Dixon JM . (2000). Br. Med. J., 321, 624–628.
Miller BA, Kolonel LN, Bernstein L, Young JL, Swanson GM, West D, Key CR, Liff JM, Glover CS and Alexander GA (eds) (1996). Racial/Ethnic patterns of cancer in the United States 1988–1992, NIH Publication No. 96-4104 National Cancer Institute: Bethesda, MD.
Muñoz N . (1988). Gastric Carcinogenesis, Reed PI and Hill MJ (eds) Elsevier Science: Amsterdam, pp. 51–69.
Muñoz N, Bosch FX, Shah KV and Meheus A . (1992). The Epidemiology of Cervical Cancer and Human Papillomavirus, IARC Scientific Publication No. 119, IARC: Lyon, France.
Muñoz N and Day NE . (1996). Cancer Epidemiology and Prevention, 2nd edn. Schottenfeld D and Fraumeni Jr JF (eds) Oxford University Press: Oxford, New York, pp. 681–706.
Muñoz N and Franceschi S . (1997). Saluda Publica Mex., 39, 318–330.
Murray CJL and Lopez A . (1996). The Global Burden of Disease. Harvard University Press: USA.
Norppa H . (1997). Environ. Health Perspect., 105, 829–835.
Parkin DM . (1989). Eur. J. Cancer Clin. Oncol., 25, 1917–1925.
Parkin DM . (2001). Lancet Oncol., 2, 533–543.
Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas J, Wabinga H and Whelan S . (2003). Cancer in Africa: Epidemiology and Prevention, IARC Scientific Publications No. 153 IARC: Lyon.
Parkin DM and Khlat M . (1996). Eur. J. Cancer, 32A, 761–771.
Parkin DM, Ohshima H, Srivatanakul P and Vatanasapt V . (1993). Cancer Epidemiol. Biomarkers Prev., 2, 537–544.
Parkin DM, Pisani P and Ferlay J . (1999a). Int. J. Cancer, 80, 827–841.
Parkin DM, Pisani P, Lopez AD and Masuyer E . (1994). Int. J. Cancer, 59, 494–504.
Parkin DM, Pisani P, Muñoz N and Ferlay J . (1999b). In: Newton N, Beral V and Weiss RA (eds). Infections and Human Cancer, Cancer Surveys, 33, 5–33.
Parkin DM, Whelan SL, Ferlay J, Teppo L and Thomas DB (eds) (2002). Cancer Incidence in Five Continents, Vol VIII, IARC Scientific Publications No. 155 IARC: Lyon, France.
Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C and Doll R . (1994). Mortality from Smoking in Developed Countries 1950–2000. Oxford University Press: Oxford.
Pham THA, Nguyen NT, Herrero R, Vaccarella S, Smith JS, Nguyen TT, Nguyen HN, Nguyen BD, Ashley R, Snijders PJF, Meijer CJLM, Muñoz N, Parkin DM and Franceschi S . (2002). Int. J. Cancer, 104, 213–220.
Pisani P, Bray F and Parkin DM . (2002). Int. J. Cancer, 97, 72–81.
Pisani P, Parkin DM, Bray F and Ferlay J . (1999). Int. J. Cancer, 83, 18–29.
Prentice RL and Sheppard L . (1990). Cancer Causes Control, 1, 81–87.
Pukkala E, Söderman B, Okeanov A, Storm H, Rahu M, Hakulinen T, Becker N, Stabenow R, Bjarnadottir K, Stengrevics A, Gurevicius R, Glattre E, Zatonski W, Men T and Barlow L . (2001). The Cancer Atlas of Northern Europe, Cancer Society of Finland, Publication No. 62 Suomen Graafiset Palvelut: Helsinki.
Rose EF and McGlashan ND . (1975). Br. J. Cancer, 31, 197–206.
Rothman KJ and Greenland S . (1998). Modern Epidemiology, 2nd edn Lippincot-Raven: Philadelphia, USA.
Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie S, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, Mosavi A, Mohagheghi MA and Alimohammadian M . (2003). Int. J. Cancer, 107, 113–118.
Shibata A and Whittemore A . (1997). Prostate, 32, 65–72.
Sigurdsson K . (1995). Eur. J. Cancer, 31A, 728–734.
Silvi J . (2003). Epidemiol Bull/PAHO, 24, 1–6.
Sitas F, Yarnell J and Forman D . (1992). Gut, 33, 1582.
Smans M, Muir CS and Boyle P . (1992). Atlas of Cancer Mortality in the European Economic Community, IARC Scientific Publication No. 107 IARC: Lyon.
Tanaka H, Hiyama T, Tsukuma H, Okubo Y, Yamano H, Kitada A and Fujimoto I . (1994). Cancer Causes Control, 5, 409–413.
Tuyns AJ and Masse G . (1975). Int. J. Epidemiol., 4, 55–59.
Tuyns AJ and Masse LM . (1973). Int. J. Epidemiol., 2, 241–245.
Tyczynski J, Tarkowski W, Parkin DM and Zatonski W . (1994). Eur. J. Cancer, 30A, 478–484.
World Cancer Research Fund (WCRF) Panel (1997). Diet, Nutriton and the Prevention of Cancer: A Global Perspective. World Cancer Research Fund: Washington, USA.
World Health Organization (2002). National Cancer Control Programmes: Policies and Managerial Guidelines. WHO: Geneva.
Yatani R, Chigusa I, Akazaki K, Stemmerman GN, Welsh RA and Correa P . (1982). Int. J. Cancer, 29, 611–616.
Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, Watanabe H Fukuda H and Yoshimizu H . (2002). Carcinogenesis, 23, 1851–1859.
Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR and Coetzee GA . (1995). Cancer Epidemiol Biomarkers Prev, 4, 861–864.
Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE and Ross RK . (1994). J. Natl. Cancer Inst., 86, 712–716.
Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu Williams AH, Kolonel LN, Horn Ross PL, Rosenthal JF and Hyer MB . (1993). J. Natl. Cancer Inst., 85, 1819–1827.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is cited by
-
Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy
Topics in Catalysis (2024)
-
Molecular Heterogeneity of Cervical Cancer Among Different Ethnic/Racial Populations
Journal of Racial and Ethnic Health Disparities (2022)
-
Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer
BMC Cancer (2021)
-
Laparoscopic intersphincteric resection with hand-sewn coloanal anastomosis in the treatment of low rectal cancer: 10-year experience
European Surgery (2021)
-
Laparoscopic Proximal Gastrectomy with Jejunal Interposition for Early Proximal Gastric Cancer
Journal of Gastrointestinal Cancer (2021)